View by Year:
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.
Genes & development, Sep-15-2009;23(18):2152-65.
Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity.
The Journal of biological chemistry, Jun-5-2009;284(23):15390-9. Epub 2009 Mar 26.
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Apr-10-2009;27(11):1814-21. Epub 2009 Mar 9.
p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research, Mar-15-2009;15(6):2116-22. Epub 2009 Mar 10.
Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors.
Endocrine-related cancer, Mar-2009;16(1):267-79. Epub 2008 Nov 5.
Sall2 is a novel p75NTR-interacting protein that links NGF signalling to cell cycle progression and neurite outgrowth.
The EMBO journal, Feb-4-2009;28(3):261-73. Epub 2009 Jan 08.
Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancers.
Surgery, Dec-2008;144(6):908-13; discussion 913-4.
The Sall2 transcription factor is a novel p75NTR binding protein that promotes the development and function of neurons.
Annals of the New York Academy of Sciences, Nov-2008;1144:53-5.
Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity.
Journal of immunology (Baltimore, Md. : 1950), Jul-15-2008;181(2):1288-98.
Association of family history with cancer recurrence and survival among patients with stage III colon cancer.
JAMA : the journal of the American Medical Association, Jun-4-2008;299(21):2515-23.
Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, May-2008;21(5):517-24. Epub 2008 Jan 18.
Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1alpha and Hdm2.
Cancer research, Jan-15-2007;67(2):450-4.
The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells.
The Journal of biological chemistry, Jan-5-2007;282(1):445-53. Epub 2006 Nov 1.
Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal cancer correlates with tumor differentiation.
Cancer gene therapy, Aug-2006;13(8):792-7. Epub 2006 Apr 21.
Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells.
Cancer research, Aug-1-2006;66(15):7509-15.